ArticleInternational urology and nephrology2023

Are SGLT-2 inhibitors "the elephant in the room" of non-diabetic glomerulonephritis? Considerations about the background immunosuppressive treatment.

Dimitrios Patoulias et al.PubMed ↗Publisher ↗

No numbers read from the abstract.